Literature DB >> 21943146

Preoperative radiological characterization of hepatic angiomyolipoma using magnetic resonance imaging and contrast-enhanced ultrasonography: a case report.

Stephanie Krebs1, Irene Esposito, Christian Lersch, Jochen Gaa, Roland M Schmid, Oliver Ebert.   

Abstract

INTRODUCTION: A hepatic angiomyolipoma is a rare benign tumor of the liver composed of a mixture of smooth muscle cells, blood vessels and a variable amount of adipose tissue. Differentiating them from malignant liver tumors can often be very difficult. CASE
PRESENTATION: We report the case of a 43-year-old Caucasian man presenting with a large liver mass in the right lobe. The results of magnetic resonance imaging and contrast-enhanced ultrasonography were consistent with a well-demarcated adipose tissue- containing tumor, showing prolonged hyperperfusion in comparison with the surrounding liver tissue. Surgery was performed and the diagnosis of hepatic angiomyolipoma was made with histopathology.
CONCLUSION: Preoperative radiological characterization using magnetic resonance imaging and contrast-enhanced ultrasonography may improve diagnostic accuracy of hepatic angiomyolipoma. Identification of smooth muscle cells, blood vessels and adipose tissue with a positive immunohistochemical reaction for HMB-45 is the final evidence for an angiomyolipoma.

Entities:  

Year:  2011        PMID: 21943146      PMCID: PMC3189154          DOI: 10.1186/1752-1947-5-481

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  7 in total

1.  Diagnosis and treatment of hepatic angiomyolipoma in 26 cases.

Authors:  Ning Ren; Lun-Xiu Qin; Zhao-You Tang; Zhi-Quan Wu; Jia Fan
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

2.  Diagnosis and treatment of hepatic angiomyolipoma.

Authors:  Guang-Hui Ding; Yang Liu; Meng-Chao Wu; Guang-Shun Yang; Jia-Mei Yang; Wen-Ming Cong
Journal:  J Surg Oncol       Date:  2011-01-31       Impact factor: 3.454

3.  Real-time contrast-enhanced ultrasonography of resected and immunohistochemically proven hepatic angiomyolipomas.

Authors:  Rui Li; Xiaohang Zhang; Xing Hua; Ping Cai; Hua Zhong; Yanli Guo; Shiyi Ding; XiaoChu Yan
Journal:  Abdom Imaging       Date:  2010-12

4.  Characteristics and treatment strategy of hepatic angiomyolipoma: a series of 94 patients collected from four institutions.

Authors:  Zhi- Gang Chang; Jin Ming Zhang; Jiao Qian Ying; Yu Ping Ge
Journal:  J Gastrointestin Liver Dis       Date:  2011-03       Impact factor: 2.008

5.  Common and epithelioid variants of hepatic angiomyolipoma exhibit clonal growth and share a distinctive immunophenotype.

Authors:  P Flemming; U Lehmann; T Becker; J Klempnauer; H Kreipe
Journal:  Hepatology       Date:  2000-08       Impact factor: 17.425

Review 6.  Hepatic angiomyolipoma.

Authors:  Amber A Petrolla; Wei Xin
Journal:  Arch Pathol Lab Med       Date:  2008-10       Impact factor: 5.534

7.  Management of hepatic angiomyolipoma.

Authors:  Ching-Yao Yang; Ming-Chih Ho; Yung-Ming Jeng; Rey-Heng Hu; Yao-Ming Wu; Po-Huang Lee
Journal:  J Gastrointest Surg       Date:  2007-04       Impact factor: 3.452

  7 in total
  4 in total

1.  Hepatocellular carcinoma with concomitant hepatic angiomyolipoma and cavernous hemangioma in one patient.

Authors:  Xiao-Wen Ge; Hai-Ying Zeng; Akesu Su-Jie; Min Du; Yuan Ji; Yun-Shan Tan; Ying-Yong Hou; Jian-Fang Xu
Journal:  World J Gastroenterol       Date:  2015-03-21       Impact factor: 5.742

2.  Malignant potential of epithelioid angiomyolipomas of the liver: A case report and comprehensive review of the literature.

Authors:  Zoe Garoufalia; Nikolaos Machairas; Ioannis D Kostakis; Aliki Liakea; Petros Tsaparas; George Liapis; Georgios C Sotiropoulos
Journal:  Mol Clin Oncol       Date:  2018-06-15

3.  Hepatic angiomyolipoma: diagnostic findings and management.

Authors:  Kenya Kamimura; Minoru Nomoto; Yutaka Aoyagi
Journal:  Int J Hepatol       Date:  2012-12-23

4.  Immunohistochemical character of hepatic angiomyolipoma: for its management.

Authors:  Yuka Kobayashi; Kenya Kamimura; Minoru Nomoto; Soichi Sugitani; Yutaka Aoyagi
Journal:  Case Rep Med       Date:  2013-06-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.